HOPE-1_TrialChart – Spyryx Biosciences

PIPELINE
TRIALS
Science
- SPX-101
- PUBLICATIONS
team
- LEADERSHIP
- BOARD OF DIRECTORS
PRESS
COMMUNITY
- EVENTS
- VOICES
Contact

News : Latest News, Press Releases & Events

HOPE-1_TrialChart

October 16, 2017

Related

Leave a comment Cancel reply

Your email address will not be published. Required fields are marked *

Categories

In The News
Press Release
Publications

Recent News & Events

SPX-101 is Stable In and Retains Function After Exposure to Cystic Fibrosis Sputum July 18, 2018
Phase 2 Study Shows Promising Results for Potential Mucus Clearance Drug June 8, 2018
Spyryx SPX-101 Phase 2 HOPE-1 Trial Shows Improvement in Lung Function in Patients with Cystic Fibrosis via Novel Modulation of ENaC June 6, 2018
Data from Spyryx Biosciences’ HOPE-1 Phase 2 Clinical Trial to be Presented in a Late-Breaking Oral Presentation at the 41st European Cystic Fibrosis Conference May 8, 2018
Spyryx Biosciences Expands with Election of Roger Jeffs, PhD as Independent Director January 16, 2018
Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference November 1, 2017

Archives

July 2018
June 2018
May 2018
January 2018
November 2017
October 2017
June 2017
May 2017
March 2017
February 2017
November 2016
October 2016
August 2016
August 2015
June 2015

LOCATION

801-10 CAPITOLA DRIVE

DURHAM, NC 27713

919.899.9399

PIPELINE

PIPELINE

CLINICAL TRIALS

CONTACT

contact@spyryxbio.com

Copyright ® 2018 Spyryx Biosciences, Inc.
All Rights Reserved.

Related